Trial intelligence / Profile preview

Entelon 150mg for Chronic Venous Disease

NCT04882228Phase 4Unknown

Sponsor
Hanlim Pharm
Start
Jan 2021
Primary completion
Feb 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of vitis vinifera extract in chronic venous disease (CVD), sponsored by Hanlim Pharm. Status: unknown.

02

Drugs

vitis vinifera extract
03

Conditions

chronic venous disease (CVD)

Beyond the preview

Go deeper on NCT04882228.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04882228.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call